News

The Accreditation Committee of the College of American Pathologists has renewed accreditation to CENTOGENE AG based on results of a recent on-site…

Dr. Arndt Rolfs, CEO CENTOGENE, presented at JP Morgan Healthcare Conference 2017 about CENTOGENE's self-amplifying business model - diagnostics,…

For the first time, ever, the Parkinson’s Institute and Clinical Center and CENTOGENE have entered into a collaboration aimed at genetic screening of…

Arndt Rolfs, CEO and founder of CENTOGENE, will present the company’s business model on Wednesday, January 11, 2017, at 4:30 pm PST.

CENTOGENE announces today a new sequencing facility for rare hereditary disorders, which will use Illumina’s HiSeq X® sequencer.

The “Deutschlandstipendium” is a scholarship that helps support gifted and talented students enrolled at German universities that are public…

CENTOGENE is proud to contribute to the Face2Gene 60 Day Challenge. This initiative by FDNA was started November 1, 2016.

CENTOGENE successfully became part of the Illumina Propel Certification Program for Core and Service Labs.

CENTOGENE AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of CENTOGENE’s unique genomic…

With the upcoming release of CentoMD® 3.1 end of September 2016, CENTOGENE will report genetic information and clinical data from more than 100,000…